Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. George Boere Dairy
WARNING LETTER
•George Boere Dairy•April 10, 2013

FDA WARNING_LETTER - George Boere Dairy - April 10, 2013

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On February 28, March 26, and April 10, 2013, the FDA inspected George Boere Dairy in Menifee, California, and found violations of the Federal Food, Drug, and Cosmetic Act.

Specifically, on December 19, 2012, a cow sold for slaughter (ear tag # (b)(4)) had desfuroylceftiofur in its kidney at 4.6 ppm, exceeding the 0.4 ppm tolerance (21 C.F.R. 556.113(b)(3)(i)), rendering the food adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.

The dairy also failed to maintain treatment records, indicating unsanitary conditions where medicated animals with harmful drug residues could enter the food supply, adulterating food under section 402(a)(4) of the FD&C Act.

Furthermore, the new animal drug Excenel RTU NADA 140-890 (ceftiofur) was adulterated. The dairy administered Excenel RTU to a cow (ear tag # (b)(4)) without following approved labeling or veterinary prescription regarding treatment duration. This extralabel use is prohibited in cattle by 21 C.F.R. 530.41(a)(13

Company
George Boere Dairy
Inspection Date
April 10, 2013
Product Type
Drugs
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Hugo Cornejo (Cofounder )
Open in Dashboard

ID · df66899f-f4c5-43f1-9d2f-212618fd9231

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.113(b)(3)(i)21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 530.41(a)(13)21 CFR 530.11(d)21 CFR 530

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.